Search
Now showing items 1-5 of 5
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
(2011)
Standard-dose HSV-2 suppressive therapy (acyclovir 400 mg twice daily) reduces plasma HIV-1 levels by 0.25-0.50 log(10) copies/mL. It is not known if higher doses might further suppress HIV-1 levels.
METHODS:
We enrolled ...
Epidemiology of syphilis in Kenya: results from a nationally representative serological survey.
(2011)
OBJECTIVES:
The authors used data from the Kenya AIDS Indicator Survey (KAIS) 2007 to determine the prevalence of syphilis and associated risk factors among adults aged 15-64 years.
METHODS:
KAIS was a nationally ...
Dosing regimens of oral ciprofloxacin for children with severe malnutrition: a population pharmacokinetic study with Monte Carlo simulation
(University of Nairobi, 2011)
BACKGROUND:
Severe malnutrition is frequently complicated by sepsis, leading to high case fatality. Oral ciprofloxacin is a potential alternative to the standard parenteral ampicillin/gentamicin combination, but its ...
Diagnosis of oral and cutaneous Kaposi’s sarcoma in Africa: Challenges involving histology and molecular detection
(University of Nairobi, 2011)
The 1st International scientific conference
(University of Nairobi, 2011-06)